Get the latest news and updates on FINTECH.TV

Pharma Under Pressure: Tariffs, Supply Chains, and Innovation Challenges

Remy Blaire is joined by David Kaplan, Pharmaceuticals Director at S&P Global, to dive into the ongoing legal battles surrounding the Trump administration’s tariff authority, particularly in relation to the pharmaceutical industry. The Court of International Trade recently ruled that Trump’s tariffs, including those on foreign-made pharmaceuticals, are illegal, prompting the Justice Department to appeal.

Advertisement

Latest articles

Related articles